Effect of Tamsulosin versus Placebo in Females with Lower Urinary Tract Symptoms Less Than 40 Years of Age
DOI:
https://doi.org/10.70749/ijbr.v3i7.2055Keywords:
Lower urinary tract symptoms, Tamsulosin, IPSS, alpha-blocker, women under 40, placebo-controlled trialAbstract
Introduction: LUTS in women chronically affects the quality of life, and, to combat it, few treatment methods are available to women below the age of 40. Tamsulosin is an alpha-1 adrenergic blocker commonly used in men whereas young women with LUTS are under-studied. Objective: To compare the average response of International Prostate Symptom Score (IPSS) due to treatment using Tamsulosin and Placebo in females less than 40 years and with LUTS after 4 weeks of treatment. Material and methods: This was a prospective, comparative cross-sectional study done in AFIU, Rawalpindi from 12th April, 2025 to 12th July, 2025. One hundred and thirty six patients were randomly assigned to take Tamsulosin 0.4 mg or placebo daily once in a period of 4 weeks. The scores of IPSS before and after treatment were noted and compared. Results: The improvement of the IPSS was substantially superior in the Tamsulosin group (7.9 + 2.8) than in the placebo (2.4 + 2.5; p < 0.001). It was a well-tolerated treatment. Conclusion: Tamsulosin is a safe and effective therapy of LUTS syndrome in young girls
Downloads
References
1. Lee AW, Kenfield SA, Wang EY, Enriquez A, Oni-Orisan A, Steinman MA, Sim I, Breyer BN, Bauer SR. Tracking lower urinary tract symptoms and tamsulosin side effects among older men using a mobile app (PERSONAL): feasibility and usability study. JMIR Formative Research. 2021 Dec 10;5(12):e30762.
2. Kang TW, Kim SJ, Chang KD, Kim MH, Chung HC. Effect of symptom-based alpha-blocker treatment on lower urinary tract symptoms in women: systematic review and meta-analysis. Therapeutic advances in urology. 2021 Oct;13:17562872211053679.
https://doi.org/10.1177/17562872211053679
3. Sinsomboon O, Noppakulsatit P, Tassanarong A, Tungsukruthai P, Sriyakul K. A comparison of effectiveness of Thai traditional massage and Tamsulosin in lower urinary tract symptoms: a randomized controlled trial. Journal of evidence-based integrative medicine. 2022 Jan;27:2515690X211068825.
https://doi.org/10.1177/2515690x211068825
4. Herschorn S, McVary KT, Santos JC, Foley S, Kristy RM, Choudhury N, Hairston J, Kaplan SA. Mirabegron vs placebo add-on therapy in men with overactive bladder symptoms receiving tamsulosin for underlying benign prostatic hyperplasia: a safety analysis from the randomized, phase 4 PLUS study. Urology. 2021 Jan 1;147:235-42.
https://doi.org/10.1016/j.urology.2020.09.040
5. Johnson II TM, Goode PS, Hammontree L, Markland AD, Vaughan CP, Ouslander JG, Falk K, McGwin Jr G, Burgio KL. An exploratory analysis of tamsulosin for overactive bladder (OAB) in men with varying voiding symptom burden. Urology. 2021 Jul 1;153:42-8.
https://doi.org/10.1016/j.urology.2021.01.022
6. Leffelman A, Chill H, Paya-Ten C, Hadizadeh A, Lee J, Chang C, Rostaminia G. Effect of preoperative tamsulosin on postoperative urinary retention prevention after sling placement: a randomized controlled trial. International Urogynecology Journal. 2025 Apr 12:1-9.
https://doi.org/10.1007/s00192-025-06120-2
7. Choi CI, Kim JK, Choo MS, Lee SH, Chang JD, Han JH. Preventive effects of tamsulosin for postoperative urinary retention after lower limb arthroplasty: a randomized controlled study. Investigative and clinical urology. 2021 Aug 3;62(5):569.
https://doi.org/10.4111/icu.20200523
8. Wu Y, Li G, Zhou H, Wu A, Tan G, Huang S, Chen G, Chen X, Li Z. Mirabegron add-on tamsulosin for men with overactive bladder symptoms: a pooled analysis of four randomized controlled trials. Urologia Internationalis. 2024 Apr 2;108(2):118-27.
https://doi.org/10.1159/000536110
9. Rughani A, Cushing D, Lary CW, Cox S, Jumper B, Johnson N, Florman J. Does tamsulosin decrease postoperative urinary retention in spine surgery? A double-blind, randomized controlled trial. Journal of neurosurgery. 2022 Feb 11;137(4):1172-9.
https://doi.org/10.3171/2021.10.jns212393
10. Hanna P, Fahmy MA, Hussein MM, El-Din AA. Prospective randomized study on the efficacy of tamsulosin, solifenacin, and their combination in relieving lower urinary tract symptoms in ureteric stent patients: insights from the brief-form Chinese USSQ. World Journal of Urology. 2025 May 16;43(1):313.
https://doi.org/10.1007/s00345-025-05695-1
11. Wee CB, Kim TH, Tae JH, Choi SY. Efficacy and Safety of Silodosin for the Treatment of Female LUTS: A 12‐Week Prospective, Single‐Center Study. LUTS: Lower Urinary Tract Symptoms. 2025 Jan;17(1):e70005.
https://doi.org/10.1111/luts.70005
12. Falahatkar S, Akhavan A, Esmaeili S, Amin A, Kazemnezhad E, Jafari A. Efficacy of tamsulosin versus tadalafil as medical expulsive therapy on stone expulsion in patients with distal ureteral stones: A randomized double-blind clinical trial. International braz j urol. 2021 Jul 30;47(5):982-8.
https://doi.org/10.1590/s1677-5538.ibju.2020.1007
13. Abou-Farha M, Hagras A, Nagla S. Effect of dose reduction of dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement. Urology Annals. 2024 Apr 1;16(2):120-4.
https://doi.org/10.4103/ua.ua_15_22
14. Mari A, Antonelli A, Cindolo L, Fusco F, Minervini A, De Nunzio C. Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: A systematic review of the literature and narrative synthesis. Therapeutic advances in urology. 2021 Apr;13:1756287221993283.
https://doi.org/10.1177/1756287221993283
15. Sajid MT, Rehman SU, Akmal M, Hussain A, Mirza ZI, Mahmood A. Comparison Of Solifenacin Versus Combination Of Solifenacin And Tamsulosin In Improving Unilateral Double-J Stent Related Lower Urinary Tract Symptoms. Pakistan Armed Forces Medical Journal. 2021 Feb 28(1):45.
https://doi.org/10.51253/pafmj.v71i1.2617
16. Shin D, Yoon BI, Bang S, Bae WJ, Ha US, Kim S, Piao J, Kim JH, Koo GB, Jeon KH, Kim TH. Safety and Efficacy assessment of red ginseng oil (rxgin) in men with lower urinary tract symptoms in a randomized, double-blind, placebo-controlled trial. The World Journal of Men's Health. 2023 Aug 29;42(1):229.
https://doi.org/10.5534/wjmh.230172
17. Zhou Z, Gan W, Li Z, Li Z, Zhou F, Li H, Liu Z. Can prophylactic tamsulosin reduce the risk of urinary retention after surgery? A systematic review and meta-analysis of randomized control trials. International Journal of Surgery. 2023 Mar 1;109(3):438-48.
https://doi.org/10.1097/js9.0000000000000267
18. Chu PS, Leung CL, Cheung MH, Woo SW, Lo TK, Chan TN, Wong WK. Hong Kong Geriatrics Society and Hong Kong Urological Association consensus on personalised management of male lower urinary tract symptoms in the era of multiple co-morbidities and polypharmacy. Hong Kong Medical Journal. 2021 Apr 1;27(2):127.
https://doi.org/10.12809/hkmj209049
19. Goberdhan S, Blachman-Braun R, Nackeeran S, Masterson 3rd TA, Ramasamy R. Is tadalafil associated with decreased risk of major adverse cardiac events or venous thromboembolism in men with lower urinary tract symptoms?. World journal of urology. 2022 Jul;40(7):1799-803.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
